Patients carrying early premature truncations of apoB seem to have a more pronounced NAFLD phenotype [25] than patients with late truncations or with single-amino-acid changes in the apoB protein [4]. This evidence concerns the gene APOB and metabolic dysfunction-associated steatotic liver disease.